White House National Drug Strategy Raises Alarm on High-Potency Marijuana, Affirms Federal Hemp THC Ban
Federal Schedule III Reclassification Prompts State-Level Medical Cannabis Expansion and Regulatory Adjustments
CSQ Introduces EU GMP Addendum to Facilitate Cannabinoid Export Compliance for European Markets
U.S. House Advances Farm Bill, Establishing Separate Regulatory Pathways for Industrial Hemp and Cannabinoid Crops
Exploring Medical Cannabis for Seniors: Enhancing Quality of Life in Later Years
Study Highlights Adverse Events Associated with Medical Cannabis Use in Minnesota Program
DEA Classifies Synthetic Cannabinoid HHC as Schedule I Substance; Texas Hemp Sales Face New Rulings
Australian Medical Cannabis Sales Decline 28.5% Amid Increased Regulatory Enforcement
Israel Health Ministry Proposes Significant Tightening of Medical Cannabis Regulation
Warrnambool Driver Retains Licence Following Medical Cannabis Prescription Defence
Home My Profile
